Introduction {#S1}
============

Cytokinesis is a fundamental biological phenomenon in all organisms. However, in eukaryotes the mechanisms are diverse. A significant difference exists between a group of animals, fungi, and Amoebozoa (Amorphea; [@B5]) and the other groups (Excavates and Diaphoretickes) ([Figure 1A](#F1){ref-type="fig"}). Cells of Amorphea generally divide depending on constriction of the contractile ring ([@B55]; [Figure 1A](#F1){ref-type="fig"}), whereas those of other eukaryotic groups lack myosin-II, an essential ring component ([@B43]; [Figure 1A](#F1){ref-type="fig"}). The mechanism of cytokinesis has varied further in each group during evolution. One example is the cytokinesis of land plants whose cells divide by developing cell walls and membranes from the cell center toward the cell periphery ([@B46]). Our current knowledge of cytokinesis mostly depends on a limited number of model organisms. However, the mechanisms in different lineages warrant exploration to reveal the eukaryotic history and the core mechanisms of cytokinesis shared by eukaryotes.

![Distribution of representative proteins in the contractile ring, EF1α, and ESCRT in eukaryotes that divide centripetally and a scheme for *C. merolae* cytokinesis. **(A)** The phylogenetic tree is based on [@B5]. Branch length does not represent evolutionary distance. Amorphea generally divide depending on the actomyosin contractile ring. Other eukaryotes lack myosin-II, an essential component of the contractile ring. Septins are part of the contractile ring in animal cells, whereas in fungal cells, they form separate ring structures. Some contractile ring components are found in the intercellular bridge (ICB), which is not depicted in the figure. Protein localization (to the cleavage furrow or intercellular bridge) or the presence of genes in species were investigated by literature and/or BLAST searching.BLAST searching was conducted using the following protein sequences as the query: *Saccharomyces cerevisiae* Act1 for *C. paradoxa* actin, *Saccharomyces cerevisiae* septins (Cdc3, Cdc10, Cdc11, Cdc12, and Shs1) for *C. merolae* septins, *S. cerevisiae* Tef1 for EF1α in the species with " + " marks in the EF1α column, and *S. cerevisiae* Vps2 and Vps4 for ESCRT in sea urchin and *Cyanophora*. References are listed on the right: 1, [@B55]; 2, [@B6]; 3, [@B16]; 4, [@B28]; 5, [@B53]; 6, [@B9]; 7, [@B24]; 8, [@B32]; 9, [@B78]; 10, [@B35]; 11, [@B48]; 12, [@B56]; 13, [@B21]; 14, [@B63]; 15, [@B86]; 16, [@B54]; 17, [@B29]; 18, [@B50]; 19, [@B77]; 20, [@B81]; 21, [@B12]; 22, [@B80]; 23, [@B68]; 24, [@B31]; 25, [@B40]; 26, [@B69]. ^∗^Information from several sea urchin species, including *Strongylcentrotus purpuratus* and *Hemicentrotus pulcherrimus*, was combined. ^∗∗^Information from *Trypanosoma brucei* and *Trypanosoma cruzi*. ^∗∗∗^Both Vps2 and Vps4 homologs were found. Blank, the genome information is unavailable or incomplete. LECA, the last eukaryotic common ancestor. **(B)** A 12 h/12 h light and dark cycle synchronized *C. merolae* cell division. Cytokinesis occurs in the dark period after the nuclear division. EF1α accumulates at the cleavage furrow in the early constriction stage and becomes dispersed in the late constriction stage. Cleavage of the intercellular stage occurs at the abscission stage.](fcell-08-00169-g001){#F1}

In mammalian cells, cytokinesis proceeds by equatorial membrane furrowing followed by abscission of the intercellular bridge. The contractile ring containing actomyosin and septin filaments constricts to furrow the membrane ([@B25]). As the ring closes, the midbody, the platform for the abscission machinery where the plus and minus ends of spindle microtubules overlap, is formed. The actin-capping protein that controls actin polymerization is required for the process ([@B74]). The intercellular bridge contains the spindle midzone microtubules and midbody. The septin filaments are reorganized into rings in the early intercellular bridge to assist bridge maturation ([@B57]; [@B33]).

The endosomal sorting complex required for transport (ESCRT), a protein complex conserved among eukaryotes ([Table 1](#T1){ref-type="table"}), contributes to various membrane fusion/fission events such as multivesicular body formation at late endosomes and nuclear envelope fusion ([@B6]; [@B61]). In mammalian cells, ESCRT mediates scission of the intercellular bridge ([@B8]; [@B45]; [@B14]; [@B26]; [@B6]; [@B61]). The proteins comprising ESCRT-I--IV, the four subcomplexes of ESCRT, are sequentially targeted to the midbody. ESCRT-I recruits charged multivesicular body protein (CHMP) 4 in ESCRT-III by binding to CHMP6 in ESCRT-III by itself or through ESCRT-II ([@B10]). CHMP6 is a nucleation factor for ESCRT-III. A recent study showed that Septin (SEPT) 9, a constituent of the septin ring, associates with the ESCRT-I protein tumor susceptibility gene (TSG) 101 to assist the recruitment of ESCRT-II and demarcate the sites for ESCRT-III assembly ([@B33]). The septin ring disassembles as ESCRT-III machinery develops ([@B33]). In addition to ESCRT-I, the ESCRT-III adaptor protein apoptosis-linked gene-2-interacting protein X (ALIX) localizes at the midbody to separately recruit CHMP4 without binding to CHMP6 ([@B10]).

###### 

Major ESCRT and ESCRT-associated proteins in eukaryotes and archaea.

                                 Eukaryotes                                               Archaea               
  ----------- ------------------ ------------ ------------------------ ------------------ --------------------- -----------------------
  ESCRT-I     [TSG101]{.ul}      Vps23        **TSG101/CMK136C**                                                \+ (Steadiness box)
              VPS28\*            Vps28        VPS28/CMN120C                                                     \+
              VPS37A--D          Vps37        \-                                                                
              MVB12A, B          Mvb12        \-                                                                
  ESCRT-II    [EAP20]{.ul}       Vps25        EAP20/CMM195C                                                     \+
              EAP30\*            Vps22        EAP30/CMO296C                                                     \+ (Vps22/36-like)
              EAP45              Vps36        \-                                                                
  ESCRT-III   [CHMP1A, B]{.ul}   Did2/Vps46   **CHMP1/CMQ376C**        CHMP-like:         CHMP-like:            \+ (Vps2/24/46-like)
                                              **CHMP1/CMR340C**        [CdvB]{.ul},       ESCRT-III,            
              [CHMP2A, B]{.ul}   Vps2         **CHMP2/CMB008C**        Saci_0451,         [ESCRT-III-1]{.ul},   
              [CHMP3]{.ul}       Vps24        \-                       Saci_1416,         [ESCRT-III-2]{.ul},   
              [CHMP4A-C]{.ul}    Vps32/Snf7   **CHMP4/CMI044C**        Saci_1601          ESCRT-III-3           \+ (Vps20/32/60-like)
              [CHMP5]{.ul}       Vps60        **CHMP5/VIG1/CML153C**                                            
              [CHMP6]{.ul}       Vps20        **CHMP6/CMQ184C**                                                 
              CHMP7              \-           \-                                                                
              [IST1]{.ul}        Ist1         \-                                                                
  ESCRT-IV    [VPS4A]{.ul}, B    Vps4         **VPS4/CMO281C**         [Vps4/CdvC]{.ul}   Vps4/CdvC             \+
              LIP5               Vta1         LIP5/CMI268C                                                      
  ALIX        [ALIX]{.ul}        Bro1         **ALIX/CMC051C**                                                  \+ (Bro1 domain)
  CdvA        \-                 \-           \-                       [CdvA]{.ul}        CdvA                  

The list of proteins in mammals and

S. cerevisiae

excluding CdvA is based on

Schuh and Audhya (2014)

. In the

C. merolae

genome, ESCRT and ALIX homologs were searched by BLAST using

S. cerevisiae

sequences as queries. The results for ESCRT homologs were consistent with those of

Leung et al. (2008)

. CdvA homologs in eukaryotes were searched by BLAST using the

S. acidocaldarius

sequence as a query. "−" no detectable homologs. The information of

Sulfolobus

is based on

Lindas et al. (2008)

;

Samson et al. (2008)

, and

Liu et al. (2017)

. Both

Sulfolobus

species have four CHMP family proteins. It is unclear which eukaryotic CHMP protein is the closest. "+" indicates that the homologous sequence is present in the genomes of "Asgard" archaea, the group proposed to be the closest to eukaryotes (

Zaremba-Niedzwiedzka et al., 2017

). Blank indicates that the protein or gene is not mentioned in the above results. Underlined proteins localize at the midbody or intercellular bridge (mammals) or between daughter nucleoids (

Sulfolobus

). The references are in this legend or the text.

∗

VPS28 and EAP30 are required for midbody localization of TSG101 and EAP20, respectively (

Christ et al., 2016

). Proteins in bold font were examined in this study.

ESCRT-III consists of CHMP family proteins, which are homologous to each other, and increased sodium tolerance (IST) 1 ([Table 1](#T1){ref-type="table"}). They are coiled-coil proteins suggested to polymerize into spiral filaments beneath the intercellular bridge membrane to narrow abscission sites adjacent to the midbody ([@B26]; [@B41]; [@B22]). ESCRT-III also recruits the microtubule-severing enzyme spastin ([@B82]; [@B11]). The intercellular bridge is cleaved after the arrival of vacuolar protein sorting (VPS) 4, the AAA-ATPase in ESCRT-IV, which regulates the turnover of ESCRT-III assembly ([@B8]; [@B45]; [@B14]; [@B62]; [@B41]).

ESCRT possibly represents conserved machinery in eukaryotic cytokinesis inherited from the archaeal ancestor. In *Sulfolobus*, a thermophile archaeon, homologs of ESCRT-III proteins and VPS4, and the ESCRT-III scaffold cell division protein (Cdv) A are detected between daughter nucleoids of dividing cells, correlating with the site of membrane ingression ([Table 1](#T1){ref-type="table"}; [@B37]; [@B58], [@B59]; [@B38]). They are necessary for cytokinesis from early to final stages. Whereas ESCRT-dependent cytokinesis is not universal in archaea ([@B39]), recent studies support that eukaryotes have diverged from archaea encoding ESCRT ([@B85]; [Table 1](#T1){ref-type="table"}). However, in eukaryotes other than in animals, whether ESCRT mediates cytokinetic abscission is poorly understood. In the land plant *Arabidopsis thaliana*, *elc* mutation, a mutation of TSG101, results in the production of multinucleated cells ([@B64]). Although the mechanism underlying induction of the phenotype is unclear, it may reflect conserved functions of ESCRT in eukaryotic cytokinetic abscission. Some similarities between the animal midbody and plant phragmoplasts, arrays of microtubules on the division plane, have been indicated in a previous study ([@B52]).

Because ESCRT is a conserved multifunctional complex, the presence of ESCRT genes in the genome does not necessarily suggest its involvement in cytokinesis. To determine whether ESCRT is primordial core machinery for eukaryotic cytokinesis, we explored ESCRT functions in the acidothermophilic unicellular red alga *Cyanidioschyzon merolae* that branched early in eukaryotic evolution ([@B83], [@B84]). In addition to the phylogenetical position, *C. merolae* provides an excellent experimental system. The cell (∼2 μm in diameter) has a simple structure ([@B34]). The genome (16.5 Mb, 5335 genes) has been completely sequenced ([@B40]; [@B49]). Genetic transformation is feasible ([@B51]; [@B19]), and a light and dark cycle highly synchronizes cell cycle progression and thus the timing of cytokinesis in a population ([@B67]; [Supplementary Figure S1A](#DS1){ref-type="supplementary-material"}).

Unlike other algae and plants, *C. merolae* does not have a rigid cell wall. It divides through membrane furrowing at the equator (constriction stage) that takes several minutes, followed by scission of the intercellular bridge (abscission stage), a stage that completes within a minute ([Figure 1B](#F1){ref-type="fig"}; [Supplementary Figures S1A,B](#DS1){ref-type="supplementary-material"}). *C. merolae* lacks the actomyosin contractile ring and septins ([Figure 1A](#F1){ref-type="fig"}). The actin gene does not seem to be expressed in *C. merolae*, and staining with phalloidin, which detects F-actin, is negative ([@B68]; [@B69]; [@B40]). Moreover, no myosin heavy chain gene or septin genes are present in the *C. merolae* genome ([@B40]). The only protein that has been linked to *C. merolae* cytokinesis is elongation factor (EF) 1α, which accumulates at the cleavage furrow ([Figure 1B](#F1){ref-type="fig"}, [Supplementary Figure S2](#DS1){ref-type="supplementary-material"}; [@B31]), as observed in *Tetrahymena* ([@B50]) and sea urchin eggs ([@B16]). Sea urchin EF1α bundles actin filaments and maintains the contractile ring structure ([@B16]). However, in *C. merolae*, actin filaments are probably absent and thus the function of EF1α in cytokinesis is unclear.

In this study, we investigated localization of ESCRT proteins in *C. merolae* by immunofluorescence and examined the effects of a dominant-negative mutant of VPS4 on cytokinesis. Five homologs of ESCRT-III proteins (CHMP1, CHMP2, and CHMP4--6), ALIX, and VPS4 localized at the intercellular bridge before cytokinetic abscission. ALIX also located close to the cleavage furrow early in the constriction stage. The expression of mutant VPS4 caused abscission failure, indicating that ESCRT mediates cytokinetic abscission in *C. merolae*.

Results {#S2}
=======

The *C. merolae* genome encodes homologs for 11 ESCRT proteins and ALIX ([Table 1](#T1){ref-type="table"}). We refer to these homologs according to the names of mammalian proteins except for the homolog of mammalian CHMP5, CHMP5/VIG1 (Vacuolar inheritance gene 1), which was previously characterized in *C. merolae* ([@B18]; [@B79]). To understand ESCRT functions in cytokinesis, we first examined the localization of ESCRT-III, the structure most directly involved in membrane deformation. We labeled CHMP2 using specific antibodies ([Supplementary Figure S3A](#DS1){ref-type="supplementary-material"}). In a synchronized culture under a light-dark cycle, the protein was expressed throughout the cell cycle with an increased level during the dark period ([Supplementary Figure S3B](#DS1){ref-type="supplementary-material"}). Immunofluorescence showed that CHMP2 localized on the punctate cytoplasmic structures and intercellular bridge of cytokinesis ([Figure 2A](#F2){ref-type="fig"}). Next, we examined whether other ESCRT-III components localize with CHMP2 at the intercellular bridge using strains that ectopically expressed proteins fused to hemagglutinin (HA)-tags. *C. merolae* encodes two CHMP1 homologs (CMR340C and CMQ376C; [Table 1](#T1){ref-type="table"}). CHMP1-HA (CMR340C) localized at the intercellular bridge with CHMP2 ([Figure 2B](#F2){ref-type="fig"}). CHMP1-HA (CMQ376C) was not expressed consistently with the lack of the expressed sequence tag (EST) of the native gene (data not shown; [@B40]). CHMP4-HA, CHMP5/VIG1-HA, and CHMP6-HA localized at the intercellular bridge with CHMP2 ([Figure 2B](#F2){ref-type="fig"}).

![Localization of ESCRT-III proteins. **(A)** WT cells were fixed and labeled with anti-α-tubulin and anti-CHMP2 antibodies. A schematic representation is shown on the right. Because of the short duration of abscission, we found very few cells with the intercellular bridge. CHMP2 localization at the intercellular bridge was confirmed in 10 cells at the abscission stage (a total of three independent experiments). **(B)** Cells expressing CHMP1 (CMR340C)-HA, CHMP4-HA, CHMP5/VIG1-HA, or CHMP6-HA were fixed and labeled with anti-HA and anti-CHMP2 antibodies. Representative cells at the abscission stage are shown. *n* ≥ 5 cells were analyzed in two independent experiments for each strain. Arrowheads indicate the position of the intercellular bridge. BF, bright field. nu, cell nucleus; cp, chloroplast. Scale bars, 2 μm.](fcell-08-00169-g002){#F2}

To further examine the involvement of ESCRT in *C. merolae* cytokinesis, we detected the localization TSG101, a major component of ESCRT-I, and ALIX. TSG101-HA was detected on the cytoplasmic puncta, but not on the intercellular bridge ([Figure 3A](#F3){ref-type="fig"}). Although we also tested N-terminally tagged HA-TSG101, it was not expressed (data not shown). In contrast to TSG101, FLAG-tagged ALIX localized to the intercellular bridge ([Figure 3B](#F3){ref-type="fig"} and [Supplementary Figures S4A,B](#DS1){ref-type="supplementary-material"}). During early constriction, ALIX-FLAG also located around the cleavage furrow ([Figures 3C,D](#F3){ref-type="fig"} and [Supplementary Figures S4A,B](#DS1){ref-type="supplementary-material"}). The signals partially overlapped with those of EF1α ([Figures 3C,D](#F3){ref-type="fig"}). In the other stages (G1, M, and late constriction), ALIX-FLAG was mainly localized close to the cell membrane and on some cytoplasmic structures ([Supplementary Figures S4A,B](#DS1){ref-type="supplementary-material"}).

![Localization of TSG101 and ALIX. **(A)** Images of a cell expressing TSG101-HA at the abscission stage. The fixed cell was labeled with anti-HA and anti-CHMP2 antibodies. Representative images are shown. Five cells at the abscission stage were analyzed in two independent experiments. **(B)** ALIX-FLAG cells were fixed and labeled with anti-FLAG and anti-CHMP2. Eight cells were analyzed in two independent experiments. **(C)** ALIX-FLAG cells were labeled with anti-FLAG and anti-EF1α antibodies, \>30 cells were analyzed in each experiment (*n* = 2). **(D)** Heat map of the signal intensities in C. Arrowheads, the position of the intercellular bridge. Asterisks, the position of the cleavage furrow where ALIX-FLAG and EF1α localized. BF, bright field. Scale bars, 2 μm.](fcell-08-00169-g003){#F3}

Our attempts to knock out some ESCRT genes were unsuccessful, suggesting that ESCRT disruption is lethal in *C. merolae*. An ATPase-inactive dominant-negative mutant of VPS4 blocks cytokinetic abscission in mammalian cells ([@B8]; [@B45]). To further clarify the role of ESCRT in cytokinesis, we expressed the corresponding mutant VPS4 (E292Q) in *C. merolae* cells.

When expressed under control of the native promoter sequence, VPS4-HA localized on the intercellular bridge ([Figure 4A](#F4){ref-type="fig"}). To assess the effect of the mutation on cytokinesis, wild-type (^WT^) or the mutant (^E292Q^) *VPS4-HA* were expressed under the control of a heat-inducible promoter in the synchronized culture. The cells were subjected to heat treatments at the beginning of the dark period (G2/M phase, as shown in [Figures 1B](#F1){ref-type="fig"}, [4B,C](#F4){ref-type="fig"}). VPS4^WT^-HA cells completed cell division in 12 h after the onset of heat shock, which was similar to untreated cells ([Figures 4D,E](#F4){ref-type="fig"}). In contrast, induction of VPS4^E292Q^-HA accumulated cells with notably elongated intercellular bridges ([Figures 4D,F--H](#F4){ref-type="fig"}). Most of these long intercellular bridges were spanned by the spindle ([Figure 5A](#F5){ref-type="fig"}) and positive for VPS4^E292Q^-HA and CHMP2 ([Figure 5B](#F5){ref-type="fig"}).

![Heat shock induction of the mutant VPS4. **(A)** Immunofluorescence of cells expressing VPS4-HA under control of the native promoter sequence. The fixed cell was labeled with anti-HA and anti-CHMP2 antibodies. Representative images are shown. Five cells were analyzed in two independent experiments. Arrowheads, the position of the intercellular bridge. **(B)** Schematic representation of heat treatments performed in **(C--H)**. Cells harboring the *VPS4^WT^-HA* or *VPS4^E292Q^-HA* gene under the control of the heat-inducible promoter were synchronized by a 12 h light/12 h dark cycle at 42°C, the optimal growth temperature for wildtype cells. The culture was exposed to a higher temperature (50°C) for 1 h twice with a 1 h interval at the beginning of the dark period. **(C)** Immunoblotting of VPS4^WT^-HA and VPS4^E292Q^-HA. Proteins were extracted from cells collected at the indicated time point after the onset of the heat shocks. Total proteins were loaded in each lane and labeled with anti-HA antibodies. Some of the membrane was stained with Coomassie Brilliant Blue (CBB) as a loading control, *n* = 3. **(D)** DAPI staining of cells harboring heat-inducible *VPS4^WT^-HA* or *VPS4^E292Q^-HA*. The cells were fixed and stained before (0 h) and after the onset of heat shocks (3 and 12 h). Merged images of DAPI (blue), autofluorescence from chloroplasts (red), and phase contrast are shown. White arrows indicate cells with a long intercellular bridge. **(E) and (F)** Percentages of cells at the indicated cell cycle stages among cells harboring the *VPS4^WT^-HA* **(E)** or *VPS4^E292Q^-HA* **(F)**. "Intercellular bridge" includes cells at the abscission stage and those with an elongated intercellular bridge. **(G)** Length of the intercellular bridge at 3 h. Data from 15 cells (*n* = 5, three independent experiments) are shown in each column. Bars indicate the mean ± standard deviation. *p*, *p*-value of the Student's *t*-test. **(H)** Length of the intercellular bridge in cells expressing VPS4^E292Q^-HA at the indicated time point. Thirty cells (*n* = 10, three independent experiments) were analyzed in each column. Scale bars, 2 μm.](fcell-08-00169-g004){#F4}

![Localization of the spindle, mutant VPS4, and CHMP2. **(A,B)** Cells harboring heat-inducible *VPS4^E292Q^-HA* were fixed at 12 h after the start of heat shocks and then labeled with anti-HA and anti-α-tubulin **(A)** or anti-CHMP2 antibodies **(B)**. Representative images are shown. More than 30 cells with a long intercellular bridge (\>1 μm) were imaged in each experiment (*n* = 3). The results showed that 94.5 ± 3.7% of the long intercellular bridges were positive for spindles, and 94.1 ± 5.3% were positive for VPS4^E292Q^-HA that colocalized with CHMP2. Arrowheads, locations of the VPS4E292Q-HA signal on the long intercellular bridge. BF, bright field. Scale bars, 2 μm.](fcell-08-00169-g005){#F5}

Discussion {#S3}
==========

ESCRT potentially represents a component of the most ancient conserved machinery for cytokinetic abscission in eukaryotes. However, little is known about such ESCRT functions in eukaryotes other than in animals. In this study, we revealed that ESCRT is an essential component for cytokinetic abscission in *C. merolae*, an early diverged eukaryote.

We found that five ESCRT-III proteins, CHMP1 (CMR340C), CHMP2, CHMP4, CHMP5/VIG1, and CHMP6, localized at the intercellular bridge of *C. merolae* ([Figures 6A,B](#F6){ref-type="fig"}). In mammalian cells, CHMP1--6, including its isoforms ([@B8]; [@B45], [@B44]; [@B13]; [@B82]; [@B4]; [@B14]; [@B26]; [@B7]; [@B23]; [@B10]), and IST1 ([@B2]; [@B22]) localize at the midbody. *C. merolae* is devoid of genes encoding CHMP3 and IST1. In addition, ESCRT-III genes, except for *CHMP1*, exist as a single copy. Thus, ESCRT-III machinery in *C. merolae* is simpler in terms of protein composition. Electron microscopy has shown that mammalian ESCRT-III proteins either form or assist in forming a spiral of 17 nm-diameter filaments underlying the intercellular bridge membrane ([@B26]; [@B41]; [@B61]). The identification of such a structure is challenging in *C. merolae* because of the short duration of the abscission stage and small size of the intercellular bridge. Thus, further extensive studies are required to elucidate the structure involved in cytokinetic abscission.

![Suggested model for *C. merolae* cytokinesis. **(A)** EF1α and ALIX localized around the cleavage furrow during early constriction and are excluded during late constriction. ALIX, ESCRT-III proteins CHMP1, 2, 4, and 5, and VPS4 colocalized at the intercellular bridge in the abscission stage. **(B)** Enlarged image of the intercellular bridge before abscission.](fcell-08-00169-g006){#F6}

*C. merolae* TSG101 appeared to be absent from the intercellular bridge. Mammalian ESCRT-I and ALIX localize at the midbody to separately target ESCRT-III ([@B10]). ESCRT-I depends on CHMP6 to recruit other ESCRT-III proteins, whereas the ALIX route does not ([@B10]). *C. merolae* CHMP6 resided at the intercellular bridge ([Figures 6A,B](#F6){ref-type="fig"}). Thus, it potentially has a role unrelated to ESCRT-I. ESCRT-I is found in all major eukaryotic taxa but was secondarily lost in some species ([@B76]; [@B35]). Although we cannot completely rule out the possibility that the addition of epitope-tags altered the localization of the protein or that the antibody could not react with the protein because of poor accessibility, the absence of TSG101 from the intercellular bridge may suggest a major role of ALIX in recruiting ESCRT-III. In mammalian cells, both ESCRT-I and ALIX are recruited by centrosome protein 55 kDa (CEP55), a midbody protein. However, CEP55 is absent in *C. elegans* and *Drosophila melanogaster*, although they depend on ESCRT for cytokinetic abscission ([@B24]; [@B36]). In *Drosophila*, ALIX is recruited to the midbody by Pavarotti, a homolog of human mitotic kinesin-like protein (MKLP) 1 ([@B36]). In *C. merolae*, CEP55 or MKLP1 homologs have not been found. Thus, upstream mechanisms to recruit ESCRT appear to vary among organisms.

In contrast to TSG101, *C. merolae* ALIX was enriched at the intercellular bridge ([Figures 6A,B](#F6){ref-type="fig"}). We also detected ALIX around the cleavage furrow early in the constriction stage ([Figure 6A](#F6){ref-type="fig"}). Of related interest is CdvA, a scaffold protein for ESCRT-III in the archaea *Sulfolobus* ([@B37]; [@B59]). It localizes to the mid-region of the cell, corresponding to membrane ingression sites from the beginning to final stages of cell division. The localization precedes that of ESCRT-III ([@B59]). Because *C. merolae* and eukaryotes other than Amorphea lack the actomyosin contractile ring, understanding the role of ALIX or ESCRT in the constriction stage would be of interest for future study.

We found that VPS4 localized to the intercellular bridge ([Figures 6A,B](#F6){ref-type="fig"}). The phenotype of cells expressing VPS4^E292Q^-HA was strikingly similar to that observed after overexpression of VPS4, either WT or dominant-negative forms ([@B8]; [@B45]), or disruption of spastin ([@B11]) in mammalian cells. This phenotype is also reminiscent of that in the archaea *Sulfolobus* overexpressing truncated ESCRT-III proteins, which exhibit long intercellular bridges ([@B38]). Therefore, *C. merolae* VPS4 plays a pivotal role in scission of the intercellular bridge, as seen in these organisms. *C. merolae* VPS4^E292Q^-HA resided with CHMP2 on the long intercellular bridge, suggesting that the dynamics of ESCRT-III regulated by the AAA-ATPase activity of VPS4 are critical for cytokinetic abscission in this organism.

Finally, our data indicate that ESCRT mediates cytokinetic abscission in eukaryotic cells that lack the contractile ring and septins, and in the eukaryotic intercellular bridge that is considerably smaller than that of mammalian cells. In mammalian cells, the contractile ring is required for midbody formation ([@B30]). The polymerization state of actin controls midbody maturation which is essential for the appropriate assembly of ESCRT-III ([@B74]). The clearance of F-actin from the intercellular bridge after the furrow closure is also a limiting step in ESCRT-III recruitment ([@B15]). Septins function in both the contractile ring and intercellular bridge. They are essential for maturation and stabilization of the intercellular bridge as well as proper ESCRT-III assembly ([@B57]; [@B1]; [@B33]). The inhibitory effects of F-actin on ESCRT-III recruitment, and the role of septins in ESCRT-III assembly may be confined to animals or eukaryotic groups in which cell division is dependent on the contractile ring. The mammalian midbody is \>1 μm in diameter ([@B47]; [@B25]), and ESCRT-III is targeted for \>40 min before abscission ([@B65]). However, in *C. merolae*, the intercellular bridge is ∼200 nm in diameter and requires less than 1 min to be cleaved ([Supplementary Figure S1B](#DS1){ref-type="supplementary-material"}). Thus, *C. merolae* appears to control cytokinetic abscission more simply than in mammalian cells. Importantly, regardless of these differences and the phylogenetic distance, ESCRT components mediate cytokinetic abscission in these organisms.

In summary, we demonstrate that five ESCRT-III proteins, ALIX, and VPS4 localize at abscission sites to mediate cytokinetic abscission in *C. merolae*. We also show that ESCRT functions in cytokinesis of an organism that lacks the contractile ring and septins. The fact that ESCRT mediates cytokinesis in archaea, animals, and the early diverged red alga *C. merolae* supports the idea that ESCRT is the primordial machinery for cytokinetic abscission in eukaryotes. We expect that exploring other lineages of eukaryotes that undergo ESCRT-mediated cytokinetic abscission and characterization of their mechanisms should further advance our understanding of the conserved mechanisms and evolution of eukaryotic cytokinesis.

Materials and Methods {#S4}
=====================

Cell Culture {#S4.SS1}
------------

*C. merolae* wildtype (10D; [@B75]) and transformant cells were grown in MA2 medium ([@B51]) at 30°C under continuous light (30 μE⋅m^--2^⋅s^--1^). To synchronize cell division, the cells (OD~750~ = 2--6) were diluted to OD~750~ = 0.4 in 2 × Allen's medium ([@B3]) and subjected to a 12 h light (100 μE⋅m^--2^⋅s^--1^)/12 h dark cycle at 42°C with bubbling air (300 ml/min). Heat treatments were applied by shifting the synchronized culture to 50°C.

Strain Generation {#S4.SS2}
-----------------

The primers and plasmids used to generate strains are listed in [Supplementary Table S1](#DS1){ref-type="supplementary-material"}. All strains except for the ALIX-FLAG strain were generated by integration of DNA fragments into the upstream region of the *URA5.3* gene ([@B17]). To add tags to ESCRT proteins, plasmids containing transformation cassettes, which included the upstream (-2300 to -898 bp) of the *URA5.3* gene (CMK046C), genes encoding ESCRT proteins with their promoter region, 3 × HA-tag, the 3′ UTR of β-tubulin, and the *URA5.3* gene with the promoter region, were generated using an In-Fusion HD Cloning kit (Clontech). For *CHMP2*-, *CHMP4*-, and *CHMP5/VIG1-HA*, PCR products \#1, \#5 and one of \#2--\#4 ([Supplementary Table S1](#DS1){ref-type="supplementary-material"}) were used. For other ESCRT proteins, PCR products \#6 and one of \#7--\#11 were used. Plasmids containing a heat shock promoter ([@B66]) and VPS4-HA were generated by fusing PCR products \#12 and \#13 using the In-Fusion HD cloning kit. The plasmid for dominant-negative *VPS4-HA* (E292Q; a mutation in conserved Walker B motif; [@B27]) was prepared by In-Fusion cloning of PCR product \#14. Transformation of *C. merolae* was conducted as described previously ([@B51]; [@B17]). Briefly, the M4 strain (a point mutant of URA5.3; [@B42]) was transformed with PCR-amplified cassettes from each plasmid (\#15) using a polyethylene glycol-mediated method. The transformants were selected for uracil independence in starch placed on solidified MA2 medium ([@B19]). Establishment of the strain ALIX-FLAG was performed following the procedures of [@B71]. PCR products \#16 and \#17, corresponding to the 3′-portion (from + 997 to + 2496, where +1 is the first base position of the initiation codon) and the 3′-downstream region (from +2497 to +3996) of the CMC051C (*ALIX*) ORF, respectively, were inserted into *Stu*I-digested pMKTf ([@B70]) to construct the plasmid pMKTf-ALIX-Tagging. Subsequently, transformation cassette \#18 was amplified from pMKTf-ALIX-Tagging by PCR and used to transform the uracil-auxotroph T1 strain ([@B73]) as described previously ([@B71]). Transformants were selected on uracil-free MA2 plates using the top starch method as described previously ([@B72]).

Generation of an Antibody Against *C. merolae* CHMP2 {#S4.SS3}
----------------------------------------------------

DNA fragments encoding the CMB008C and pQE80 expression vector (Qiagen) were amplified by PCR with the primers listed in [Supplementary Table S2](#DS1){ref-type="supplementary-material"}. The fragments were fused and circularized using the In-Fusion HD cloning kit, resulting in a construct containing the six-histidine tag at the N-terminus of CMB008C. The recombinant proteins were purified with His-Trap columns (GE Healthcare Life Sciences) and used to raise antibodies in rats (T. K. craft, Ltd.).

Time-Lapse Imaging {#S4.SS4}
------------------

A synchronized culture at M phase was mounted on coverslips, which had pieces of surgical tape at the corners, and was then incubated for 30 min at room temperature. After removing excess medium, the coverslips were inverted and placed in glass-bottom dishes. The dishes were transferred into a chamber for live imaging (BZ-H3XD; Keyence) at 40°C. Images were obtained under a microscope (BZ-X700; Keyence) using a ×100 objective.

Microscopy {#S4.SS5}
----------

For immunofluorescence, cells were fixed with methanol containing 1% formaldehyde and 10% DMSO at −20°C overnight. The fixed cells were centrifuged at 1500 × *g* at 4°C, washed once with cold methanol (−20°C), and then twice with PBS. For blocking, the cells were treated with either Blocking One (Nakarai Tesque) for 15 min at 4°C or 5% BSA for 30 min at 37°C. The antibody reaction was performed for 1 h at 4°C. Primary antibodies were diluted in PBS and used at the following dilutions: 1:500 for rat anti-CHMP2, 1:100 for rabbit anti-α-tubulin ([@B20]), 1:500 for guinea pig anti-EF1α ([@B31]), 1:1000 for mouse anti-HA (Clone 16B12; BioLegend), and 1:1000 for mouse anti-DYKDDDDK tag (to detect FLAG-tag; Clone 1E6; Wako). Fluorescent secondary antibodies (Thermo Fisher Scientific) were diluted in PBS and applied at 1:1000 for Alexa Fluor 488 and 1:100 for Alexa Fluor 555. DNA was stained with 1 μg/ml 4′,6-diamidino-2-phenylindole (DAPI). Images were acquired under the BZ-X700 fluorescence microscope using the × 100 objective. For Alexa Fluor 488, the GFP filter was used. The emission filter of the TRITC filter was changed to XF3022 (580DF30; Omega Optical) for Alexa Fluor 555 to avoid signals of chloroplast autofluorescence. To analyze the length of intercellular bridges, cells were fixed with 1% glutaraldehyde and imaged under the BZ-X700 microscope using the × 100 objective. The length was measured using ImageJ software ([@B60]). For [Figure 4D](#F4){ref-type="fig"}, cells were fixed with 1% glutaraldehyde and stained with 1 μg/ml DAPI. Images were obtained under a fluorescence microscope (BX51; Olympus) with a × 40 objective and CCD camera (C7780, Hamamatsu Photonics). The following filter sets were used: U-MWU2 (Olympus) for DAPI and U-MWIG2 (Olympus) for chloroplast autofluorescence. Heat maps of the signal intensities were generated in Image Lab software (Bio-Rad). All images were adjusted for contrast using Photoshop software (Adobe Systems).

Immunoblotting {#S4.SS6}
--------------

*C. merolae* cells were collected by centrifugation at 1500 × *g* at room temperature. The cell pellets were resuspended in 2 × SDS sample buffer (100 μm Tris, pH 6.8, 12% 2-mercaptoethanol, 4% SDS, and 20% glycerol) and incubated for 3 min at 95°C. After centrifugation at 15000 × *g* for 5 min at 4°C, the protein concentration in the supernatant was measured using an XL-Bradford kit (Aproscience). Total proteins (5 μg) were separated on polyacrylamide gels and then transferred to PVDF membranes. The membranes were blocked with 5% dry skim milk. The antibodies were diluted in 5% dry skim milk and used at the following dilutions: rat anti-CHMP2 (1:10000 for [Supplementary Figure S3A](#DS1){ref-type="supplementary-material"} and 1:2000 for [Supplementary Figure S3B](#DS1){ref-type="supplementary-material"}), rabbit anti-H3S10Ph (1:2000; Merk-Millipore), and mouse anti-HA (1:5000; Clone 16B12, BioLegend). Secondary antibodies were HRP-conjugated anti-rat, anti-rabbit, or anti-mouse IgG (1:20000; Thermo Fisher scientific). The signals were detected using ECL Prime (GE Healthcare) and the imaging system ImageQuant LAS-4000mini (for [Supplementary Figure S3B](#DS1){ref-type="supplementary-material"}; GE Healthcare) or ChemiDoc Touch (Bio-Rad).
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